In part 2 of this 2-part interview, Jason Bock, founder and CEO of CTMC provides input on how the FDA's proposed manufacturing registration rule may impact personalized therapies.
Jason Bock
Advertisement
Jason Bock is founder and CEO of CTMC.
Articles by Jason Bock
Jason Bock, founder and CEO of CTMC, provides his perspective on the FDA’s proposed rule to streamline registration for single distributed manufacturing establishments, and what the change may mean for personalized medicines.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
2
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
3
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
4
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
5